The Daily Signal
Entertainment

Follow the script before the festival

Jem·Monday, November 2, 2026 Edition
Where the real gate sits

Film funding discrimination against women doesn't happen at festivals. It happens 18 months earlier, in the development offices where scripts are scored and gatekeepers decide which stories move forward to financiers. Afghan director Shahrbanoo Sadat named this mechanism at Tokyo International Film Festival. Naming it and understanding how it works are different problems — and the industry has spent a decade solving the wrong one.

Funding decisions are not made by a single committee reviewing a stack of scripts in one room. They move through layers. A script arrives at a development fund and gets assigned to a reader — someone paid to write a report on whether it warrants moving forward. That reader's assessment determines whether a development executive even sees it. The executive uses those reports plus their own judgment to score projects against criteria: commercial potential, filmmaker track record, budget discipline, thematic fit with institutional priorities. Some scripts get circulated to financiers in the ecosystem. Most don't. The ones that reach financiers have already been filtered through at least two sets of human judgment, each one an opportunity for unconscious bias to narrow the pipeline before anything reaches public view.

Festivals operate downstream from this. By the time a film is submitted to competition, the funding decision was made years earlier. Women filmmakers' rejection rates spike not at submission but at development scoring, where scripts are evaluated against thresholds set by people who control institutional capital. When festival organizers implemented diversity quotas in the 2010s, they were correcting for bias that already happened. Selecting more fairly from a pool that had already been depleted.

Why quotas miss the problem

This is why previous diversity initiatives failed at scale. They treated the exhibition layer while the disease operated in development. A quota ensures more women's work gets screened once funding has secured it. It does nothing to change the scoring mechanism that determined which scripts qualified for funding in the first place. The gatekeeping institutions. Development funds, commissioning bodies, script consultants advising financiers. Never changed how they evaluate material.

When you control a gate, you control the flow. The people running development funds are not malicious. They are executing decision systems that embed assumptions about what constitutes a viable project, and those assumptions were built by people who looked like the filmmakers they were already funding. Reform that actually moves the needle requires changing not what gets presented for selection. How the selection itself is scored. That means opening the development stage to scrutiny. Naming who evaluates scripts, what criteria they use, how those criteria were chosen. Whether anyone is measuring whether the system produces different outcomes when different kinds of evaluators apply the same rubric. Until then, every festival diversity program is a decoration on an upstream pipeline that was already closed.

Key Facts
*Development stage gatekeeping compounds unconscious bias before public competitions
*Festival diversity quotas cannot correct decisions already made upstream
*Funding rejection mechanics operate through layered reader and executive scoring
Related Stories
Insight
"I'll Just Read It Again"
Re-reading feels productive because it's easy, but the research is clear: retrieving information from memory is what actually builds it — and the discomfort is …
Food
Eighteen Ingredients Cannot Rename a Dish
When recipes add expensive or technically demanding ingredients—like bourbon and caramel to apple pie—they claim improvement while actually replacing the origin…
Film
When Fewer Films Feel More Gripping
October 2026's home entertainment slate—heavy on recycled horror and campy musicals like Frankenstein and Masters of the Universe—reveals not changing audience …
More From Today's Edition
Technology
Tavneos Approval Shows FDA Trusts Companies Before Catching Fraud
The FDA approved Tavneos in 2017 based on clinical trial data that its manufacturer appears to have fabricated, revealing a structural gap in how regulators val…
Science
What happens when the drug test comes back negative
Campus Title IX offices are now accepting sexual assault findings in cases where toxicology shows no common drugs, treating the absence of evidence as irrelevan…
View Past Editions >